Listed

Passage BIO, Inc.

PASGNasdaqCIK 1787297HealthcareFiscal year ends Dec 31

Reports and events: 143 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Passage BIO, Inc., Reports and events
FiledFormWhat it isAccession number
2026-09-0301:37 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001140361-26-035515
2026-08-1011:15 ET10-QQuarterly reportPeriod 2026-06-300001104659-26-093021
2026-07-0201:19 ETSCHEDULE 13DOwnership report, active investor0000902664-26-003000
2026-06-2420:15 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-077306
2026-05-2720:15 ET8-K1.02 Termination of a material agreement0001104659-26-066956
2026-05-2611:15 ET8-K5.07 Shareholder vote results0001104659-26-065991
2026-05-1211:01 ET10-QQuarterly reportPeriod 2026-03-310001104659-26-058987
2026-04-2811:00 ET8-K2.05 Exit or disposal costs0001104659-26-049755
2026-04-2011:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-26-045219
2026-04-0711:00 ETDEF 14AProxy statementPeriod 2026-05-190001104659-26-040130
2026-03-1011:15 ET8-K1.02 Termination of a material agreement0001104659-26-025550
2026-03-0312:15 ET10-KAnnual reportPeriod 2025-12-310001104659-26-022549
2026-03-0312:00 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-26-022539
2026-01-1212:01 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-26-002696
2025-11-1021:31 ET10-QQuarterly reportPeriod 2025-09-300001104659-25-109180
2025-11-1021:15 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-25-109158
2025-09-1820:30 ET8-K5.02 Departure or appointment of officers or directors0001104659-25-091288
2025-08-1211:15 ET10-QQuarterly reportPeriod 2025-06-300001558370-25-011146
2025-08-1211:00 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-25-011143
2025-07-2921:00 ET8-K8.01 Other events0001104659-25-071779
2025-07-2421:44 ETSCHEDULE 13D/AOwnership report, active investor, amended0000947871-25-000684
2025-07-2121:28 ETSCHEDULE 13D/AOwnership report, active investor, amended0000947871-25-000678
2025-07-1411:01 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-25-067561
2025-07-0900:06 ETSCHEDULE 13D/AOwnership report, active investor, amended0000947871-25-000657
2025-06-2311:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-25-061371
2025-05-3020:25 ET8-K5.07 Shareholder vote results0001104659-25-054907
2025-05-1311:15 ET10-QQuarterly reportPeriod 2025-03-310001558370-25-007489
2025-05-1311:00 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-25-007487
2025-04-2523:48 ETSCHEDULE 13D/AOwnership report, active investor, amended0000947871-25-000425
2025-04-1611:00 ETDEF 14AProxy statementPeriod 2025-05-280001558370-25-004877
2025-03-0412:15 ET10-KAnnual reportPeriod 2024-12-310001558370-25-002101
2025-03-0412:00 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-25-002093
2025-01-3121:06 ET8-K3.01 Delisting notice0001104659-25-008100
2025-01-1012:00 ET8-K2.02 Results of operations; 2.05 Exit or disposal costs; 2.06 Material impairments; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-25-002278
2024-12-2621:31 ETSCHEDULE 13D/AOwnership report, active investor, amended0000947871-24-001036
2024-11-1312:15 ET10-QQuarterly reportPeriod 2024-09-300001558370-24-015431
2024-11-1312:00 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-24-015429
2024-10-2411:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-24-013563
2024-09-1611:00 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001558370-24-012793
2024-09-1011:00 ET8-K5.02 Departure or appointment of officers or directors0001104659-24-098371
2024-09-0620:15 ET8-K2.06 Material impairments0001558370-24-012654
2024-08-0923:06 ETSC 13D/AOwnership report, active investor, amended0001193125-24-198056
2024-08-0811:15 ET10-QQuarterly reportPeriod 2024-06-300001558370-24-011463
2024-08-0811:00 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-24-011459
2024-08-0220:06 ET8-K3.01 Delisting notice0001104659-24-085360
2024-08-0111:00 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-24-084615
2024-07-1611:01 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001558370-24-009826
2024-05-2920:35 ETSC 13D/AOwnership report, active investor, amended0001193125-24-149241
2024-05-2220:03 ET8-K5.07 Shareholder vote results0001104659-24-064243
2024-05-1411:15 ET10-QQuarterly reportPeriod 2024-03-310001558370-24-008058

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.